Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00061074 · ClinicalTrials.gov registry record · Phase 1
Tobacco Cessation in Postmenopausal Women (Part II) - 2
A Phase 1 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT00061074 is a Phase 1 study that has completed, run by University of Minnesota. The registered enrollment target is 1 participants.
The verdict
NCT00061074, a Phase 1 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of ERT on appetitive behavior and withdrawal in short-term smoking cessation in postmenopausal females on transdermal nicotine replacement
Interventions
- DRUG Nicotrol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 1993-03 |
| Est. Completion | 2000-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00061074
The ClinicalTrials.gov registry entry for NCT00061074 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nicotrol is the first listed.
NCT00061074 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00061074 about?
NCT00061074 is a clinical study titled "Tobacco Cessation in Postmenopausal Women (Part II) - 2". The purpose of this study is to evaluate the effects of ERT on appetitive behavior and withdrawal in short-term smoking cessation in postmenopausal females on transdermal nicotine replacement
What is the current status of trial NCT00061074?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 1993-03. Estimated completion is 2000-03.
What interventions are being tested in trial NCT00061074?
The interventions under investigation include: Nicotrol (DRUG).
Who is sponsoring clinical trial NCT00061074?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.